Stellar Biotechnologies - 48 Year Dividend Yield History | SBOT

Historical dividend payout and yield for Stellar Biotechnologies (SBOT) since 1971. The current TTM dividend payout for Stellar Biotechnologies (SBOT) as of February 20, 2019 is $0.00. The current dividend yield for Stellar Biotechnologies as of February 20, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.006B $0.000B
Stellar Biotechnologies, Inc. is engaged in the development, manufacture and commercialization of keyhole limpet hemocyanin and technologies. The Company's principle products consist of: stellar KLH protein and stellar KLH ELISA Kits. KLH is a component for cancer vaccines and anticipated therapeutic vaccines, including those for lymphoma, sarcoma, small cell lung cancer, Alzheimer's disease, rheumatoid arthritis, lupus and Post Traumatic Stress Disorder chemical dependencies. It operates primarily in the United States, Europe, and Asia. Stellar Biotechnologies, Inc. is headquartered in Port Hueneme, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.347B 12.98
Gilead Sciences (GILD) United States $86.362B 10.84
Bio-Techne Corp (TECH) United States $7.246B 48.82